Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | (Q6)Sep 30, 2020 | (FY)Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -16.51%512.17M | -11.71%1.25B | -30.00%613.43M | 158.12%1.42B | --876.32M | 454.34%550.03M | 25.96%59.77M | -32.56%99.22M | -36.30%47.45M | 10.11%147.13M |
| Operating income | -16.51%512.17M | -11.71%1.25B | -30.00%613.43M | 158.12%1.42B | 876.32M | 454.34%550.03M | 25.96%59.77M | -32.56%99.22M | -36.30%47.45M | 10.11%147.13M |
| Cost of sales | 19.97%-420.94M | 9.75%-1.1B | 15.16%-525.96M | -206.25%-1.21B | ---619.93M | -1,204.40%-396.42M | -17.25%-18.49M | 38.99%-30.39M | 42.04%-15.77M | -0.33%-49.82M |
| Operating expenses | 19.97%-420.94M | 9.75%-1.1B | 15.16%-525.96M | -206.25%-1.21B | -619.93M | -1,204.40%-396.42M | -17.25%-18.49M | 38.99%-30.39M | 42.04%-15.77M | -0.33%-49.82M |
| Gross profit | 4.30%91.23M | -23.29%157.84M | -65.89%87.47M | 33.94%205.75M | 256.4M | 123.17%153.61M | 30.28%41.28M | -29.26%68.83M | -32.99%31.69M | 15.90%97.31M |
| Selling expenses | -2.21%-52.38M | 19.52%-107.38M | 68.97%-51.24M | -49.41%-133.44M | ---165.14M | -89.12%-89.31M | -43.04%-33M | 17.07%-47.22M | 15.88%-23.07M | -21.67%-56.94M |
| Administrative expenses | -32.32%-38.19M | -42.13%-72.47M | -41.17%-28.86M | 37.54%-50.99M | ---20.44M | -643.12%-81.64M | -60.26%-8.12M | -4.54%-10.99M | -8.95%-5.07M | -24.01%-10.51M |
| Impairment and provision | -103.25%-6.57M | -34.66%-141.31M | 63.77%-3.23M | -1,820.22%-104.94M | ---8.92M | ---5.47M | ---- | ---- | --122K | -742.11%-244K |
| -Impairment of intangible assets | ---- | ---55.24M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Goodwill impairment | ---- | 57.45%-37.56M | ---- | ---88.27M | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other impairment is provision | -103.25%-6.57M | -191.03%-48.52M | 63.77%-3.23M | -205.03%-16.67M | ---8.92M | ---5.47M | ---- | ---- | --122K | -742.11%-244K |
| Special items of operating profit | 264.96%10.26M | 36.89%15.58M | -27.53%2.81M | 18.75%11.38M | --3.88M | 30.26%9.58M | 91.25%8.35M | 193.78%7.36M | 231.32%4.37M | -519.07%-7.85M |
| Operating profit | -37.26%4.36M | -104.53%-147.75M | -89.44%6.95M | -446.56%-72.24M | 65.77M | -173.51%-13.22M | 5.92%8.52M | -17.40%17.98M | -32.39%8.04M | -28.85%21.77M |
| Financing cost | -53.57%-1.06M | 1.74%-4.35M | 69.39%-687K | -485.05%-4.42M | ---2.24M | -1.75%-756K | -18.60%-491K | 24.65%-743K | 13.93%-414K | 10.20%-986K |
| Share of profits of associates | -63.84%392K | -80.87%1.35M | 41.70%1.08M | 11,459.68%7.04M | --765K | ---62K | ---- | ---- | ---- | ---- |
| Special items of earning before tax | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --244K | ---- | ---- |
| Earning before tax | -49.69%3.69M | -116.53%-150.75M | -88.58%7.34M | -396.04%-69.62M | 64.29M | -180.29%-14.04M | 5.23%8.03M | -15.88%17.48M | -33.17%7.63M | -29.55%20.78M |
| Tax | 20.16%-3.15M | 273.53%8.26M | 9.83%-3.94M | 49.59%-4.76M | ---4.37M | -80.68%-9.44M | -40.00%-2.88M | 24.85%-5.23M | 42.43%-2.06M | -3.08%-6.96M |
| After-tax profit from continuing operations | -83.96%545K | -91.56%-142.49M | -94.33%3.4M | -216.79%-74.38M | 59.92M | -291.60%-23.48M | -7.64%5.14M | -11.38%12.25M | -28.94%5.57M | -39.22%13.83M |
| Earning after tax | -83.96%545K | -91.56%-142.49M | -94.33%3.4M | -216.79%-74.38M | 59.92M | -291.60%-23.48M | -7.64%5.14M | -11.38%12.25M | -28.94%5.57M | -39.22%13.83M |
| Minority profit | -165.27%-1.34M | -37.75%737K | -89.17%2.06M | -72.95%1.18M | --19.02M | 87.69%4.38M | -56.15%692K | -20.33%2.33M | -5.23%1.58M | 38.72%2.93M |
| Profit attributable to shareholders | 41.08%1.89M | -89.54%-143.22M | -96.73%1.34M | -171.27%-75.56M | 40.9M | -380.75%-27.86M | 11.56%4.45M | -8.97%9.92M | -35.34%3.99M | -47.19%10.9M |
| Basic earnings per share | 0.00%0.002 | -50.00%-0.18 | -96.67%0.002 | -140.00%-0.12 | 0.06 | -350.00%-0.05 | 23.46%0.01 | -31.27%0.02 | -50.61%0.0081 | -47.09%0.0291 |
| Diluted earnings per share | 0.00%0.002 | -50.00%-0.18 | -96.67%0.002 | -140.00%-0.12 | 0.06 | -350.00%-0.05 | 23.46%0.01 | -31.27%0.02 | -50.61%0.0081 | -47.09%0.0291 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | MYR | MYR | MYR |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Suya Wenshun Certified Public Accountants Co., Ltd | -- | Kaiyuan Shun Tak Certified Public Accountants Limited | -- | Kaiyuan Shun Tak Certified Public Accountants Limited | -- | Malaysia Zhitong Certified Public Accountants, CCA Zhonghuan (Hong Kong) Certified Public Accountants Limited | -- | Malaysia Zhitong Certified Public Accountants, CCA Zhonghuan (Hong Kong) Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.